Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
BlueVoyant acquisition of Conquest Cyber
We are advising BlueVoyant on the acquisition
Lightyear Capital strategic investment in Inszone Insurance
We are advising Lightyear Capital on the strategic investment and related financing arrangements
Telefónica tender offer for Telefónica Deutschland
We are advising Telefónica on the tender offer
Abu Dhabi Investment Authority investment in Reliance Retail Ventures
We advised Reliance Retail Ventures on the transaction
Reliance Industries’ Reliance Retail Ventures investment by KKR
We advised Reliance on the transaction
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Sibanye-Stillwater $211.5 million acquisition of Reldan
We are advising Sibanye-Stillwater on the acquisition
WeWork chapter 11 filing
We are advising an ad hoc group of secured noteholders in connection with WeWork’s restructuring
Symphony Technology Group $660 million Avid Technologies acquisition financing
We advised the administrative agent, joint lead arrangers and initial lenders on the acquisition financing
Williams acquisitions of Cureton and Rocky Mountain Midstream
We are advising Williams on the acquisitions